MENU
ANRO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Alto Neuroscience (ANRO) Ownership - Who owns Alto Neuroscience?
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options... Show more
Profile
Industry
N/A
Address
369 South San Antonio Road
Phone
+1 650 200-0412
Employees
63
Web
https://www.altoneuroscience.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
48.73M
P/E Ratio
N/A
Total Cash
181.7M
Projected Growth
N/A
Total Debt
16.79M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.71
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ANRO
Capitalization
48.7M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
182M
Total Cash/Share
6.71
Total Debt
16.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
165M
P/B Ratio
0.32
Cash Flow
N/A
Earnings
-2.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
13.09
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-55.61M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-46.93
Shares Held By Institutions
122M
Shares Outstanding - Current
27.1M
Total Liabilities
26.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-57.447
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
369 South San Antonio Road
Phone
+1 650 200-0412
Employees
63
Web
https://www.altoneuroscience.com